Position in INCY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$268,272,865
+$5,167,074 QoQ
Shares Held
2,850,328
+7.0% QoQ
Ownership
1.43%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 74.37463337552731.ToString("F0")%
Shared 0.ToString("F0")%
None 25.62536662447269.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. INCY ranks #12 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $268,272,865 | 2,850,328 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $263,105,791 | 2,663,823 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $223,960,813 | 2,640,736 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $176,702,877 | 2,594,756 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $183,457,774 | 3,029,856 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $195,957,593 | 2,837,087 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $141,870,952 | 2,146,308 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $136,666,206 | 2,254,474 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $166,484,451 | 2,922,318 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $210,704,273 | 3,355,698 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $122,457,258 | 2,119,738 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $120,283,616 | 1,932,267 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $137,230,387 | 1,898,857 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $151,557,086 | 1,886,916 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $98,011,176 | 1,470,756 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $138,008,770 | 1,816,622 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $101,012,784 | 1,271,881 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $57,583,985 | 784,523 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $55,027,298 | 800,048 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $51,029,384 | 606,554 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $47,637,789 | 586,167 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $53,769,291 | 618,180 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $43,036,608 | 479,570 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $39,483,643 | 379,760 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $25,034,624 | 341,863 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||